Palmidrol

DB14043InvestigationalNutraceuticalSmall molecule

A cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection. Palmidrol is available for human use as a supplement (400 mg capsules) and as food...

Chemical structure of Palmidrol
Formula / weight
C18H37NO2 · 299.4919 g/mol (avg)
Also known as
Hydroxyethylpalmitamide · Monoethanolamine palmitic acid amide · N-hexadecanoylethanolamine · N-palmitoylethanolamine · Palmitamide MEA

Resolves to

Compound
UNII6R8T1UDM3VCAS544-31-0ChEMBLCHEMBL417675ChEBI71464KEGGD08328
Clinical / RWD
RxNorm2001986
Structure
InChIKeyHXYVTAGFYLMHSO-UHFFFAOYSA-NSMILESCCCCCCCCCCCCCCCC(=O)NCCO
Targets
P34972CNR2Q9Y2T6GPR55Q8TDV5GPR119

What you can answer from here — as of April 23, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
841Drug interactionsStructured to mechanism, not free text
Sign in
26Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Palmidrol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In